Latest News in the pharma Industry

Top Stories

Regeneron Ends Patent Litigation with Genentech

Regeneron Ends Patent Litigation with Genentech

4 Jan 2012

Under the terms of the Agreement, Regeneron will make payments to Genentech based on U.S. sales of EYLEA through May 7, 2016.

Read more 
Alexion Pharmaceuticals to Acquire Enobia Pharma

Alexion Pharmaceuticals to Acquire Enobia Pharma

30 Dec 2011

Alexion Pharmaceuticals plans to buy drug developer Enobia Pharma in a deal that could be worth $1.08 billion.

Read more 
OPKO Completes Acquisition of FineTech Pharmaceutical

OPKO Completes Acquisition of FineTech Pharmaceutical

30 Dec 2011

OPKO Health has completed the acquisition of Israel-based FineTech which produces high potency active pharmaceutical ingredients.

Read more 
Immunomedics & UCB Amend Epratuzumab Deal

Immunomedics & UCB Amend Epratuzumab Deal

29 Dec 2011

The restructuring provides UCB with the flexibility to select a partner to sublicense its rights for certain territories.

Read more 
Pharmexcil Expects More International Exposure with New Council Name

Pharmexcil Expects More International Exposure with New Council Name

29 Dec 2011

The change in the council’s name is to have a better visibility and to give more exposure of the council’s activities in the national and international forums.

Read more 
BI to Expand Manufacturing Plant in China

BI to Expand Manufacturing Plant in China

28 Dec 2011

Boehringer Ingelheim is investing €70m in China to expand its Shanghai manufacturing facility.

Read more 
Eisai Resubmits Perampanel NDA to FDA

Eisai Resubmits Perampanel NDA to FDA

27 Dec 2011

Eisai has resubmitted the New Drug Application for the investigational AMPA-type glutamate receptor antagonist perampanel.

Read more 
Karo Bio Forms Research Collaboration with Pfizer

Karo Bio Forms Research Collaboration with Pfizer

27 Dec 2011

The collaboration aims to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.

Read more 
Marina Biotech & Mirna Therapeutics Ink Oncology Pact

Marina Biotech & Mirna Therapeutics Ink Oncology Pact

26 Dec 2011

Marina Biotech could receive up to $63 million in total up-front fees as well as clinical and commercialization milestone payments over and above royalties on sales.

Read more 
Takeda & MSD to End Co-promotion Deal for Daxas

Takeda & MSD to End Co-promotion Deal for Daxas

26 Dec 2011

Takeda will use its own sales organization to market the once-daily tablet for patients with chronic obstructive pulmonary disease.

Read more 
Baxter & Momenta Ink Biosimilars Pact

Baxter & Momenta Ink Biosimilars Pact

23 Dec 2011

Baxter will make an upfront cash payment of $33 million to Momenta related to the collaboration for as many as six follow-on biologic compounds.

Read more 
Takeda Acquires Intellikine to Boost Oncology Pipeline

Takeda Acquires Intellikine to Boost Oncology Pipeline

23 Dec 2011

The transaction is expected to be finalised in January 2012 under an agreement worth $190m upfront and up to $120m in additional potential clinical development milestone payments.

Read more